Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02685267
Title Docetaxel/Prednisone Versus Docetaxel/Prednisone and Enzalutamide in Castration-Resistant Prostate Cancer (Doce/Enza)
Recruitment Unknown status
Gender male
Phase Phase II
Variant Requirements No
Sponsors Prostate Cancer Clinical Trials Consortium
Indications

prostate adenocarcinoma

Therapies

Docetaxel + Enzalutamide + Prednisone

Docetaxel + Prednisone

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.